Apimeds Pharmaceuticals US, Inc. Share Price
NASDAQ: APUS
Live Apimeds Pharmaceuticals US, Inc. Share Price Chart
O H L
Apimeds Pharmaceuticals US, Inc. Performance Overview
Days Range
▼
$1.68Low
$1.85High
Markets Today
| Previous Close | $1.67 |
|---|---|
| Open | $1.68 |
| Volume | 998,940 |
| Day's Range | $1.68 - $1.85 |
| 52W Range | NA |
| Market Cap | $2.41 M |
Historical Performance
| 1M Returns | -58.25 |
|---|---|
| 3M Returns | -84.68 |
| 6M Returns | -90.23 |
| 1Y Returns | -90.87 |
| 5Y Returns | NA |
| 10Y Returns | NA |
Apimeds Pharmaceuticals US, Inc. Fundamentals
| Market Cap | $2.41 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-11.91 M |
| Profit Margin | N/A |
| Market Cap | $2.41 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-11.91 M |
| Profit Margin | N/A |
Apimeds Pharmaceuticals US, Inc. Profit & Loss
Quarterly
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$2.66 M | -$1.84 M | -$7.04 M | -$12.19 M | -$6.28 M |
| EBITDA | -$2.66 M | -$1.84 M | -$7.04 M | -$12.17 M | -$6.26 M |
| Interest Expense | -$23.05 K | -$6.30 K | -$215.62 K | -$859.40 K | -$3.22 M |
| Depreciation | $232 | $1.49 K | $3.98 K | $20.04 K | $20.28 K |
| Income Before Tax | -$2.66 M | -$1.78 M | -$1.16 M | -$35.06 M | -$20.17 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$2.66 M | -$1.78 M | -$1.16 M | -$35.06 M | -$20.17 M |
| Net Profit Margin | - | - | - | - | - |
Apimeds Pharmaceuticals US, Inc. Financials Balance Sheet In USD
Quarterly
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Share Capital | $125.76 K | $125.76 K | $1.26 K | $8.24 M | $3.64 M |
| Reserve & Surplus | -$7.46 M | -$9.24 M | -$10.39 M | -$45.45 M | -$65.63 M |
| Non-Current Liabilities | $0 | $0 | $129.45 K | $118.81 K | $101.87 K |
| Current Liabilities | $809.00 K | $1.09 M | $10.71 M | $14.58 M | $21.07 M |
| Total Liabilities | $809.00 K | $1.09 M | $10.84 M | $14.70 M | $21.18 M |
| Fixed Assets | $13.14 K | $34.19 K | $149.94 M | $127.87 M | $116.79 M |
| Current Assets | $10.35 M | $9.09 M | $13.98 M | $13.15 M | $10.68 M |
| Total Assets | $10.55 M | $9.25 M | $164.18 M | $141.22 M | $127.62 M |
Apimeds Pharmaceuticals US, Inc. Cash Flow
Quarterly
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Net Income | -$2.66 M | -$1.78 M | -$1.16 M | -$35.06 M | -$20.17 M |
| Operating Cash Flow | -$3.36 M | -$1.73 M | -$3.82 M | -$2.07 M | -$5.67 M |
| Investing Cash Flow | -$13.37 K | -$22.54 K | -$10.02 M | $490.61 K | $1.50 M |
| Financing Cash Flow | $11.86 M | $0 | $8.49 M | $920.00 K | $3.47 M |
| Change in Cash | $8.48 M | -$1.75 M | -$5.35 M | -$657.12 K | -$701.16 K |
Apimeds Pharmaceuticals US, Inc. Return Calculator
The Apimeds Pharmaceuticals US, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Apimeds Pharmaceuticals US, Inc.
Apimeds Pharmaceuticals Us Inc is a development-stage biopharmaceutical company. The Company operates its biopharmaceutical business. Its primary focus is the clinical development of Apitox, a purified honeybee venom-based drug candidate being evaluated for the treatment of pain and inflammation associated with knee osteoarthritis. The Company operates in two segments: the biopharmaceutical segment, which is focused on the clinical development of Apitox through Lokahi, and the digital asset operations segment, which encompasses the holding, sale, and advancement of the MindWaveDAO blockchain and related digital assets through MindWave.
Popular Stocks
FAQs
What is the share price of Apimeds Pharmaceuticals US, Inc. today?
Apimeds Pharmaceuticals US, Inc. (APUS) share price as of September 18, 2026 is $1.79. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Apimeds Pharmaceuticals US, Inc.?
Yes, Indian Investors can invest in the Apimeds Pharmaceuticals US, Inc. (APUS) Share by opening an international trading account with Angel One.
How can I purchase Apimeds Pharmaceuticals US, Inc. shares in India?
Purchasing Apimeds Pharmaceuticals US, Inc. (APUS) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Apimeds Pharmaceuticals US, Inc. (APUS) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Apimeds Pharmaceuticals US, Inc.?
Yes, you can purchase fractional shares of Apimeds Pharmaceuticals US, Inc. (APUS) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Apimeds Pharmaceuticals US, Inc.?
The market capitalization of Apimeds Pharmaceuticals US, Inc. on September 18, 2026, is $2.41 M.
In which sector Apimeds Pharmaceuticals US, Inc. belongs?
Apimeds Pharmaceuticals US, Inc. operates in the null sector, specifically in the null industry.
What documents are required to invest in Apimeds Pharmaceuticals US, Inc. stocks?
In order to invest in Apimeds Pharmaceuticals US, Inc. (APUS) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
